第一作者:
Yanwen,Xue
第一单位:
School of Medical Laboratory, Shandong Second Medical University, Weifang, 261053, Shandong, China.;Shandong Advanced Academy Engineering Research Institute of Precision Medicine Innovation and Transformation of Infections Diseases, Shandong Second Medical University, Weifang, 261053, Shandong, China.
作者:
医学主题词
白血病(Leukemia);分子靶向治疗(Molecular Targeted Therapy);受体, 嘌呤能P2X7(Receptors, Purinergic P2X7);疾病恶化(Disease Progression);多态性, 单核苷酸(Polymorphism, Single Nucleotide);人类(Humans);动物(Animals);嘌呤能P2X受体拮抗剂(Purinergic P2X Receptor Antagonists)
DOI
10.1007/s11302-025-10108-4
PMID
40844672
发布时间
2026-04-29
- 浏览0
Purinergic signalling
1249-1260页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



